Should You Investigate Encompass Health Corporation (NYSE:EHC) At US$68.04?
Should You Investigate Encompass Health Corporation (NYSE:EHC) At US$68.04?
While Encompass Health Corporation (NYSE:EHC) might not have the largest market cap around , it saw a double-digit share price rise of over 10% in the past couple of months on the NYSE. The company is inching closer to its yearly highs following the recent share price climb. As a mid-cap stock with high coverage by analysts, you could assume any recent changes in the company's outlook is already priced into the stock. However, could the stock still be trading at a relatively cheap price? Let's examine Encompass Health's valuation and outlook in more detail to determine if there's still a bargain opportunity.
儘管Encompass Health Corporation(紐約證券交易所代碼:EHC)的市值可能不是最大的,但在過去幾個月中,紐約證券交易所的股價上漲了兩位數,漲幅超過10%。在最近股價上漲之後,該公司已接近年度高點。作爲分析師報道率高的中型股票,你可以假設該公司前景的任何最近變化都已計入該股。但是,該股票還能以相對便宜的價格交易嗎?讓我們更詳細地研究Encomass Health的估值和前景,以確定是否還有討價還價的機會。
See our latest analysis for Encompass Health
查看我們對 Encompass Health
What's The Opportunity In Encompass Health?
Encompass Health 的機會是什麼?
Good news, investors! Encompass Health is still a bargain right now. According to our valuation, the intrinsic value for the stock is $91.32, which is above what the market is valuing the company at the moment. This indicates a potential opportunity to buy low. Another thing to keep in mind is that Encompass Health's share price may be quite stable relative to the rest of the market, as indicated by its low beta. This means that if you believe the current share price should move towards its intrinsic value over time, a low beta could suggest it is not likely to reach that level anytime soon, and once it's there, it may be hard to fall back down into an attractive buying range again.
好消息,投資者!目前,Encompass Health 仍然很划算。根據我們的估值,該股票的內在價值爲91.32美元,高於市場目前對公司的估值。這表明存在低價買入的潛在機會。要記住的另一件事是,Encomass Health的股價相對於其他市場可能相當穩定,其低貝塔值就表明了這一點。這意味着,如果你認爲當前的股價應該會隨着時間的推移向其內在價值,那麼低的貝塔值可能表明它不太可能在短期內達到這個水平,一旦達到這個水平,可能很難再次回落到一個有吸引力的買入區間。
What kind of growth will Encompass Health generate?
Encompass Health 將帶來什麼樣的增長?
![earnings-and-revenue-growth](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240106/0-b2e698e6b350b4bf7237f5e432b5afc4-0-91a78836ac56176e0f07dd626724d6ab.png/big)
Future outlook is an important aspect when you're looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Buying a great company with a robust outlook at a cheap price is always a good investment, so let's also take a look at the company's future expectations. With profit expected to grow by a double-digit 12% over the next couple of years, the outlook is positive for Encompass Health. It looks like higher cash flow is on the cards for the stock, which should feed into a higher share valuation.
當你考慮買入股票時,未來前景是一個重要的方面,特別是如果你是尋求投資組合增長的投資者。以低廉的價格收購一家前景看好的優秀公司永遠是一項不錯的投資,因此,讓我們也來看看公司的未來預期。預計未來幾年利潤將增長兩位數的12%,Encomass Health的前景樂觀。看來該股的現金流即將增加,這應該會促進更高的股票估值。
What This Means For You
這對你意味着什麼
Are you a shareholder? Since EHC is currently undervalued, it may be a great time to accumulate more of your holdings in the stock. With an optimistic outlook on the horizon, it seems like this growth has not yet been fully factored into the share price. However, there are also other factors such as financial health to consider, which could explain the current undervaluation.
你是股東嗎?由於EHC目前被低估,因此現在可能是積累更多股票的好時機。隨着樂觀前景的臨近,這種增長似乎尚未完全納入股價。但是,還有其他因素需要考慮,例如財務狀況,這可以解釋當前低估的原因。
Are you a potential investor? If you've been keeping an eye on EHC for a while, now might be the time to enter the stock. Its prosperous future outlook isn't fully reflected in the current share price yet, which means it's not too late to buy EHC. But before you make any investment decisions, consider other factors such as the track record of its management team, in order to make a well-informed buy.
你是潛在的投資者嗎?如果你關注EHC已有一段時間了,那麼現在可能是進入股票的時候了。其繁榮的未來前景尚未完全反映在當前的股價中,這意味着現在購買EHC還爲時不晚。但是,在做出任何投資決策之前,請考慮其他因素,例如其管理團隊的往績,以便做出明智的購買。
In light of this, if you'd like to do more analysis on the company, it's vital to be informed of the risks involved. While conducting our analysis, we found that Encompass Health has 1 warning sign and it would be unwise to ignore this.
有鑑於此,如果你想對公司進行更多分析,了解所涉及的風險至關重要。在進行分析時,我們發現Encomass Health有1個警告信號,忽視這一點是不明智的。
If you are no longer interested in Encompass Health, you can use our free platform to see our list of over 50 other stocks with a high growth potential.
如果您不再對Encompass Health感興趣,可以使用我們的免費平台查看我們列出的其他50多隻具有高增長潛力的股票清單。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。